help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2188
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ukropec, J.
Right arrow Articles by Gasperíková, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ukropec, J.
Right arrow Articles by Gasperíková, D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Metabolic Disorders
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 6 2255-2262
Copyright © 2008 by The Endocrine Society

Adipokine Protein Expression Pattern in Growth Hormone Deficiency Predisposes to the Increased Fat Cell Size and the Whole Body Metabolic Derangements

Jozef Ukropec, Adela Penesová, Martina Skopková, Mikulás Pura, Miroslav Vlcek, Zofia Rádiková, Richard Imrich, Barbara Ukropcová, Mária Tajtáková, Juraj Koska, Stefan Zórad, Vítazoslav Belan, Peter Vanuga, Juraj Payer, Juergen Eckel, Iwar Klimes and Daniela Gasperíková

Institute of Experimental Endocrinology (J.U., A.P., M.S., M.V., Z.R., R.I., B.U., J.K., S.Z., I.K., D.G.), Slovak Academy of Sciences, 833 06 Bratislava, Slovakia; National Institute of Endocrinology and Diabetology (M.P., P.V.), 034 91 L’ubochna, Slovak Republic; The First Clinic of Internal Medicine (M.T.), P. J. Safárik University, 041 80 Kosice, Slovak Republic; Radiodiagnostic Clinic (V.B.) and The Fifth Clinic of Internal Medicine (J.P.), Comenius University School of Medicine, 811 08 Bratislava, Slovakia; and German Diabetes Center (J.E.), 40225 Düsseldorf, Germany

Address all correspondence and requests for reprints to: Jozef Ukropec, Ph.D., Diabetes Laboratory, Institute of Experimental Endocrinology, Centre of Excellence acknowledged by European Commission, Slovak Academy of Sciences, Vlárska 3, 833 06 Bratislava, Slovak Republic. E-mail: jozef.ukropec{at}savba.sk (http://www.endo.sav.sk/d-ldn.htm).

Context: GH deficiency (GHD) in adults is associated with central adiposity, dyslipidemia, and insulin resistance.

Objective: The objective of the study was to test the hypothesis that GHD might change the spectrum of adipokines and thus influence the adipose tissue and the whole-body metabolic and inflammatory status leading to development of insulin resistance.

Design: This was a single-center observational study with a cross-sectional design.

Participants and Methods: Protein arrays were used to characterize adipokines expressed in the sc adipose tissue obtained from young GHD adults and compared with age-, gender-, and body mass index (BMI)-matched group of healthy individuals. All subjects underwent an oral glucose tolerance test, euglycemic hyperinsulinemic clamp, and magnetic resonance imaging examination.

Results: Presence of abdominal obesity, enlarged adipocytes, increased circulating high-sensitivity C-reactive protein, impaired glucose tolerance, and decreased insulin action were found in GHD. Changes in adipokine protein expression due to GHD were highly dependent on the obesity phenotype. Lean GHD individuals (BMI ~23 kg/m2) had decreased protein levels for stem cell factor and epithelial growth factor, indicating a possible defect in adipocyte differentiation and proliferation. Decrease of vascular endothelial growth factor, stromal cell-derived factor, angiopoietin-2, and brain-derived neurotrophic factor advocated for attenuated angiogenesis and neurogenesis. Presence of obesity (BMI ~31 kg/m2) eliminated these inhibitory effects. However, adipose tissue expansion in GHD individuals was paralleled by an elevation of adipose tissue proinflammatory cytokines (IL-1β, interferon-{gamma}) and chemoattractants (interferon-inducible T cell {alpha}-chemoattractant, monocyte chemotactic protein-2, monocyte chemotactic protein-3, eotaxin).

Conclusion: Our data demonstrate that GHD modulates adipokine and cytokine protein expression pattern, which might influence the adipose tissue growth and differentiation and predispose to tissue hypoxia, inflammation, and a defect in the whole-body insulin action.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society